These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 11431698

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Are Trp53 rescue of Brca1 embryonic lethality and Trp53/Brca1 breast cancer association related?
    McAllister KA, Wiseman RW.
    Breast Cancer Res; 2002; 4(2):54-7. PubMed ID: 11879563
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression of Brca1 and splice variant Brca1delta11 RNA levels in mouse mammary gland during normal development and tumorigenesis.
    Mixon M, Kittrell F, Medina D.
    Oncogene; 2000 Nov 02; 19(46):5237-43. PubMed ID: 11077440
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation.
    Deng CX, Scott F.
    Oncogene; 2000 Feb 21; 19(8):1059-64. PubMed ID: 10713690
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. BRCA1 carries tumor suppressor activity distinct from that of p53 and p21.
    Randrianarison V, Marot D, Foray N, Cabannes J, Méret V, Connault E, Vitrat N, Opolon P, Perricaudet M, Feunteun J.
    Cancer Gene Ther; 2001 Oct 21; 8(10):759-70. PubMed ID: 11687899
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.
    Brodie SG, Xu X, Li C, Kuo A, Leder P, Deng CX.
    Oncogene; 2001 Mar 22; 20(12):1445-54. PubMed ID: 11313888
    [Abstract] [Full Text] [Related]

  • 16. Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression.
    Bouwman P, Drost R, Klijn C, Pieterse M, van der Gulden H, Song JY, Szuhai K, Jonkers J.
    J Pathol; 2011 May 22; 224(1):10-21. PubMed ID: 21404276
    [Abstract] [Full Text] [Related]

  • 17. Generation and analysis of Brca1 conditional knockout mice.
    Deng CX, Xu X.
    Methods Mol Biol; 2004 May 22; 280():185-200. PubMed ID: 15187254
    [Abstract] [Full Text] [Related]

  • 18. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H, Joosse SA, van Oostrom CT, Nederlof PM, de Vries A, Jonkers J.
    Cancer Res; 2009 Apr 15; 69(8):3625-33. PubMed ID: 19336573
    [Abstract] [Full Text] [Related]

  • 19. Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice.
    Deng CX.
    Mutat Res; 2001 Jun 02; 477(1-2):183-9. PubMed ID: 11376699
    [Abstract] [Full Text] [Related]

  • 20. The role of p53 mutation in BRCA1-associated ovarian cancer.
    Rose SL, Buller RE.
    Minerva Ginecol; 2002 Jun 02; 54(3):201-9. PubMed ID: 12063435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.